average weight loss tirzepatide first month Before and after results: what real transformations look like and what determines success Tirzepatide is a powerful tool,

Glucagon receptor activation raises energy expenditure and directly targets fat in the liver and visceral fat stores around the organs

GLP-1 Reduces appetite, slows gastric emptying GIP Enhances insulin, improves fat metabolism Glucagon Increases energy expenditure, burns fat Based on Phase 2 clinical trial data (published in NEJM, 2023), retatrutide's side effects are primarily gastrointestinal, similar to other GLP-1 agonists but with some differences due to the glucagon component

Its about using real science to address the why behind weight struggles, and pairing that with a plan tailored just for you

Busetto, R

Vomiting happens less frequently but can occur if you eat too much despite reduced appetite